SkincareBrand ReviewAug 2026

Obagi Tretinoin: What You Are Actually Buying and How to Spot a Fake

Obagi tretinoin is a prescription drug, and its paperwork is public, which means most of the questions people ask about it have documented answers. Here is what the label says the product is for, what the published trials found when the Obagi system was tested by name, and how to work out whether the box in front of you is the thing you think it is.

Obagi tretinoin listings, US FDA

Acne

The approved indication

Head-to-heads vs generic found

What Obagi Tretinoin Actually Is

Obagi tretinoin is plain tretinoin, sold under the Obagi name. Tretinoin is all-trans-retinoic acid, a metabolite of vitamin A and the active form of the whole retinoid family, which is why it works on skin without needing to be converted first. That is the same molecule whichever brand prints the carton, and the Obagi label describes it in those terms.

What Obagi adds is a vehicle, a distribution model and a price. The US drug listing shows four tretinoin products under the Obagi Cosmeceuticals labeler code, three creams and one gel. Three sit under New Drug Applications numbered in the 1970s and 1980s, and the gel is listed as an authorized generic of another company New Drug Application. That is not a criticism, it just means the brand is a wrapper around a long-established drug rather than a new one.

If you are still deciding between prescription tretinoin and an over-the-counter retinoid, the family tree is laid out in the retinoid versus retinol guide, and the direct comparison sits in tretinoin versus retinol. This page is about the brand and the box, not about which strength suits which skin.

Three Different Things Called Obagi

This is where most of the confusion in Southeast Asia starts, and it is worth clearing up before anything else, because two of the three are not fakes and people keep treating them as if they were.

Obagi Medical tretinoin (prescription drug)

Distributed by Obagi Cosmeceuticals LLC in Long Beach, California. Rx only. Three cream strengths and one gel, all in 20 g tubes, all indicated for acne vulgaris on their US labels.

Obagi retinol products (cosmetics)

Obagi sells retinol products that are not drugs and need no prescription. Retinol appears nowhere as an active ingredient in the 50 Obagi drug listings in the US FDA National Drug Code directory, which is what you would expect for a cosmetic. Note that two separate products carry the 0.5 number: the Obagi360 line has a 0.5 Smoothing Retinol, and the Obagi Clinical line has a Retinol 0.5 Retexturizing Cream. Searching for "retinol Obagi 0.5" will show you both.

Obagi Japan (a different company)

Rohto Pharmaceutical has licensed the Obagi mark in Japan since 2002 and bought the Japanese trademarks outright in November 2025 for USD 82.5 million. In announcing the sale, Waldencast described the Japanese line as having no operational or branding overlap with the global Obagi Medical brand. A Japanese Obagi box is genuine and contains no tretinoin.

So the first question is not whether your Obagi is real. It is which Obagi it is. A shopper who buys a Japanese Obagi product expecting a prescription retinoid has not been sold a counterfeit, they have been sold the wrong thing, and no authenticity check will ever surface that.

What The Label Says It Treats

The Obagi tretinoin cream and gel labels both give one indication: topical treatment of acne vulgaris. The cream label goes further and says that safety and efficacy for long-term use in other disorders have not been established. Most people buying Obagi tretinoin in this region are buying it for pigmentation and fine lines, which is not what its own approval covers.

A tretinoin cream approved in the US for wrinkles does exist. RENOVA 0.02%, under NDA021108 and held by Bausch Health, is indicated as an add-on for softening the look of fine facial wrinkles in people already using an overall skin care and sun avoidance routine. Its label is unusually honest about the ceiling: it says in capital letters that the product does not eliminate wrinkles, repair sun-damaged skin or reverse photoaging, and it notes that in the blinded trials many people in the vehicle group also got the effect they wanted from skin care and sun avoidance alone.

Obagi product	US marketing category	Application	Pack
Tretinoin Cream, 0.025%	New Drug Application	NDA019049	20 g tube, NDC 62032-414-20
Tretinoin Cream, 0.05%	New Drug Application	NDA017522	20 g tube, NDC 62032-412-20
Tretinoin Cream, 0.1%	New Drug Application	NDA017340	20 g tube, NDC 62032-417-20
Tretinoin Gel, 0.05%	NDA authorized generic	NDA022070	20 g tube, NDC 62032-413-20

Strengths appear in that table because they are printed on the carton and are part of what identifies a genuine unit. Which strength suits which skin is a separate question that this page does not answer, and it is covered in Vietnamese in tretinoin nồng độ nào phù hợp.

Two details on those labels are easy to miss and worth knowing. The gel contains fish collagen hydrolyzates, and the label carries a caution about allergenicity to fish protein for anyone with a fish allergy. The second detail is pregnancy. The gel label carries a Pregnancy Category C designation and states there are no well-controlled trials in pregnant women. The cream label does not use that category wording, but it states there are no adequate and well-controlled studies in pregnant women. Both labels report that oral tretinoin has been teratogenic in animals, in rats, mice and hamsters and in monkeys, and the gel label does convert its animal doses into human terms, giving them as multiples of the clinical dose on a body surface area comparison. The cream label goes further and reports thirty human cases of congenital malformations recorded in time association with two decades of clinical use of RETIN-A, five of them in the rare defect category holoprosencephaly. The same label states that no definite pattern of teratogenicity and no causal association have been established from those cases, and that what they mean for risk to a fetus is not known. Both labels say tretinoin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

The gel is also the one Obagi product with published side effect rates, because it is the newest application. Across the two randomised registration trials, 674 subjects received the gel and 487 were randomised to vehicle. Half of the gel group reported one or more adverse reaction of any kind and 30 percent reported one recorded as treatment-related, against 29 percent and 5 percent in the vehicle group. No serious treatment-related reactions were reported in any group. The individual reactions look like this:

Reaction	Tretinoin gel (n=674)	Vehicle gel (n=487)
Dry skin	109 (16%)	8 (2%)
Peeling, scaling or flaking skin	78 (12%)	7 (1%)
Skin burning sensation	53 (8%)	8 (2%)
Erythema (redness)	47 (7%)	1 (under 1%)
Pruritus (itching)	11 (2%)	3 (1%)
Pain of skin	7 (1%)	0 (0%)
Sunburn	7 (1%)	3 (1%)

One caveat on those trials matters for readers here. The enrolled population was 74 percent Caucasian, 15 percent Black or African American, 3 percent Asian and 8 percent other, and the label itself states the database was not large enough to assess whether effects differed by age, gender or race. Nobody has published a version of this table for a Vietnamese population.

What The Evidence Shows For The Molecule

Tretinoin as a molecule has a long trial record for photodamaged skin, and it is solid, though narrower than the marketing around it. Three studies give a fair picture.

Leyden 1989 ran a six-month randomised, double-blind, vehicle-controlled study of 0.05% tretinoin cream once daily on photodamaged facial skin, and reported significant improvement in fine wrinkling, coarse wrinkling, sallowness, looseness and hyperpigmentation, with side effects the authors described as minimal.
Weinstein 1991 randomised 251 subjects with mild to moderate photodamaged facial skin across 0.05% tretinoin, 0.01% tretinoin and vehicle. 79 percent of the people on 0.05% for 24 weeks showed overall improvement, against 48 percent on vehicle. That trial used a new emollient cream formulation, not the hydrophilic acne vehicle Obagi cream uses.
Kossard 1993 compared 28 paired biopsies from people using 0.05% tretinoin for 26 weeks against 28 paired biopsies from a vehicle group, and found a significant increase in epidermal thickness, although the same study found no effect on solar elastosis, the deeper sun damage, over that period. The authors noted that dermal repair may need longer than six months.

Read together, those results say the epidermis responds well and the deeper structural damage mostly does not, at least inside six months. That is the same ceiling the RENOVA label puts in capital letters, arrived at from the other direction. It is also why the sun protection habit does more for long-term results than the tube does, a point the retinol guide makes the same way.

Does The Obagi Brand Beat A Generic?

No published head-to-head comparing Obagi-branded tretinoin against another manufacturer of tretinoin at the same strength turned up in a PubMed search in August 2026. A title and abstract search for the brand name returns twelve records, and the clinical ones test the multi-product Nu-Derm system rather than the tretinoin tube on its own. Those Nu-Derm studies are worth reading, because they are the closest thing to evidence about the brand, and they are more mixed than the price suggests.

Pannucci 2011, Plastic and Reconstructive Surgery

Design: Multicentre double-blind RCT. 56 women with Fitzpatrick type I to IV skin and moderate to severe facial photodamage were randomised between the Obagi Nu-Derm system and standard care after a chemical peel or laser resurfacing, so roughly half of that total sat in each arm. 82 percent were followed beyond reepithelialization.

Result: No significant difference in mean time to reepithelialization between the two groups. The Nu-Derm group did have a significantly higher median erythema score on the day of surgery, after four weeks of product use, and that difference did not persist after surgery.

Fabi and Goldman 2013, Journal of Drugs in Dermatology

Design: Investigator-blinded randomised comparison over 12 weeks in women with mottled pigmentation and photodamaged facial skin. 36 completed it, 20 on the 7-product hydroquinone-containing Obagi Nu-Derm system and 16 on a 4-product hydroquinone-free system.

Result: Both regimens significantly reduced overall hyperpigmentation, mottled pigmentation, global photoaging and sallowness compared with baseline, and there were no significant differences between the two groups. Tactile roughness did improve significantly with the Obagi regimen at week 12.

Dayan 2018, Journal of Drugs in Dermatology

Design: Randomised study in 20 women who had hyaluronic acid filler and neurotoxin treatment, split into two groups, so about ten per arm. One used a basic skin care regimen afterwards, the other used Nu-Derm.

Result: Both groups improved significantly on the wrinkle and skin quality scales at 12 weeks, and there were no significant differences between the groups on those two scales. A difference on the global aesthetic improvement scale showed up at six weeks and only at six weeks.

All three are small, and two of them compared the Obagi system against something rather than against nothing, which is the harder test and the one worth having. The pattern across them is that the system works and so did the comparator, with the differences sitting in single measures rather than across the board.

There is a separate point about the hydroquinone products that share the Nu-Derm box with the tretinoin. In the US FDA National Drug Code directory there are 50 Obagi drug listings, and the four with tretinoin as an active ingredient are the four carrying a New Drug Application number. The Obagi hydroquinone products sit in the marketing category "unapproved drug other", which is a listing rather than an approval. Appearing in a drug database is not the same as being approved, and the two halves of the same kit are in different regulatory positions.

The honest read: the tretinoin in an Obagi tube is a real, approved prescription drug with a real trial record behind the molecule. What has not been shown is that the Obagi version outperforms the same molecule from another maker, and where the branded system has been tested against a comparator it has generally matched it rather than beaten it. If the premium buys you a clinic relationship and stock you can trace, that is a reason. Molecular superiority is not one the published record supports.

Checking The Box In Front Of You

Start with the limit of what a check can do. No published laboratory analysis of counterfeit Obagi product could be found, so this guide makes no claim about what is inside a fake. What it can do is describe what a genuine unit looks like on paper, because those details are public and a counterfeiter has to match all of them rather than just the front of the box.

Signal	What a genuine unit shows	Reason to stop
Which Obagi it is	A US Obagi Medical tretinoin tube is a prescription drug. A Japanese Obagi box from Rohto is a different brand under the same name and holds no tretinoin.	A seller who treats the two as interchangeable, or who cannot tell you which company made the box.
Prescription markings	The US carton and insert carry Rx only, and name Obagi Cosmeceuticals LLC, Long Beach, CA 90806 as the distributor.	A tube claiming tretinoin with no prescription marking and no distributor address at all.
Pack format	Cream and gel are both supplied in 20 g tubes with NDC codes beginning 62032.	An unusual size, a jar, a pump bottle, or an NDC that does not resolve to the labeler.
Ingredient list	The gel lists fish collagen hydrolyzates and sodium hyaluronate. The cream lists a hydrophilic vehicle of stearic acid, isopropyl myristate, polyoxyl 40 stearate, stearyl alcohol, xanthan gum, sorbic acid and butylated hydroxytoluene.	An ingredient list that matches neither, or no ingredient list printed anywhere.
Seller channel	A seller Obagi itself confirms, or a clinic that can show where the stock came from.	A marketplace listing, a social account, or any seller whose only proof is their own word. Obagi warns that diverted product may be outdated, counterfeit or compromised.
Price	In line with what clinics and authorised sellers charge.	Far under everyone else, which is the oldest bait there is.

None of those is proof on its own, and that is the point. Obagi runs an authorised retailer programme and says plainly that it does not sell to or authorise general retail chains, and that buying from an unauthorised source carries no guarantee of authenticity or proper handling. The company is the one that can confirm a seller, so the check that settles it comes from Obagi rather than from the person selling to you. The same logic runs through our counterfeit Ozempic guide and real versus fake GLP-1, because the failure mode is identical whatever the product is.

Obagi And Tretinoin In Vietnam

Vietnam regulates its own medicines, so a US application number tells you nothing about whether a specific tube is legally imported here. The Ministry of Health used to publish a list of medicines that may be sold without a prescription, issued under Circular 07/2017/TT-BYT, and tretinoin did not appear on it. That approach has been replaced. Circular 12/2025/TT-BYT, signed on 16 May 2025 and in force from 1 July 2025, ended the chemical medicines, biologicals and herbal medicines content of the older circular and set out principles and criteria for deciding whether a medicine is non-prescription instead. Classification now sits with the individual product and is settled when its registration is granted or renewed, and products classified before that date keep their classification until renewal. So there is no public list to check tretinoin against any more, which makes a pharmacist the right person to confirm the position for a product you are holding, and a dermatologist the right person for whether a retinoid suits your skin at all.

The practical point for anyone shopping here is the one from earlier. Two separate product lines legitimately carry the Obagi name, the Japanese one from Rohto and the US Obagi Medical one, and no published data on how the two are split across the Vietnamese market could be found, so this guide puts no number on it. What the trademark record does settle is that a Japanese Obagi box is real, that it is a different brand with a different formula, and that it holds no tretinoin. That is why a price comparison between a Japanese Obagi serum and a US Obagi tretinoin tube is not a comparison at all.

Heat is the other local factor. The Obagi cream label says to store it below 80 degrees Fahrenheit, about 27 degrees Celsius, and the gel label specifies controlled room temperature of 20 to 25 degrees Celsius with excursions permitted from 15 to 30. A tube that has sat in a hot room or a delivery van in a Saigon summer has been outside its stated storage conditions, and nothing on the packaging will tell you that after the fact.

The Short Version

Obagi tretinoin is ordinary tretinoin under a brand, sold as a prescription drug on four US listings: three creams under New Drug Applications and one gel listed as an authorized generic.
Its approved US indication is acne vulgaris, not wrinkles. The tretinoin cream approved in the US for fine wrinkles is a different product from a different company.
Tretinoin has a real trial record for photodamaged skin, mostly at the epidermal level. Solar elastosis did not shift in a 26-week biopsy study.
No head-to-head against generic tretinoin could be found. Where the Nu-Derm system was tested against a comparator, it generally matched rather than beat it.
The Obagi hydroquinone products in the same kit are listed as unapproved drug other, which is a listing and not an approval.
Japanese Obagi from Rohto is a separate brand under a licensed then purchased trademark, and holds no tretinoin. It is not a counterfeit.
The check that settles authenticity comes from Obagi confirming a seller, not from the seller confirming themselves.

Frequently Asked Questions

Is Obagi tretinoin prescription only?+

In the United States, yes. Every Obagi tretinoin product carries Rx only on the carton and the patient insert, and the gel insert describes it as a prescription medicine used on the skin to treat acne. Vietnam handles it differently, and the rule changed recently. The Ministry of Health list of medicines that may be sold without a prescription, issued under Circular 07/2017/TT-BYT, did not include tretinoin, but the chemical medicines, biologicals and herbal medicines part of that list stopped having effect on 1 July 2025 under Circular 12/2025/TT-BYT. There is no national list to look tretinoin up on any more. Each product is now classified as prescription or non-prescription against set criteria when its registration is granted or renewed, so a pharmacist is the right person to confirm the position for the specific product in front of you.

What is the difference between Obagi tretinoin and Obagi Retinol 0.5?+

They are two different categories of product that happen to share a brand. Obagi tretinoin is a prescription drug approved under a US New Drug Application, and its label limits it to acne vulgaris. Obagi Retinol 0.5 is a cosmetic containing retinol, which Obagi itself describes as a non-prescription retinoid. Retinol does not appear as an active ingredient in any of the 50 Obagi drug listings in the US FDA National Drug Code directory, because retinol cosmetics are not filed as drugs. There are also two separate products carrying the 0.5 number, one in the Obagi360 line and one in the Obagi Clinical line, so the number alone does not identify what you are holding.

Is Obagi tretinoin better than generic tretinoin?+

No published head-to-head trial comparing Obagi-branded tretinoin against another manufacturer of tretinoin at the same strength turned up in a PubMed search in August 2026. The three cream strengths sit under New Drug Applications that date back to the 1970s and 1980s, and the gel is listed as an authorized generic of another company New Drug Application, which means the brand name on the box does not mark out a different molecule. Where Obagi has been tested by name, it is the multi-product Nu-Derm system rather than the tretinoin tube on its own.

Is the Obagi sold in Vietnam genuine?+

No published data on how much of the Obagi sold in Vietnam is genuine could be found, so this guide puts no number on it. What the trademark record does establish is that two different product lines legitimately carry the Obagi name, which means a real box is not always the product the buyer has in mind. Rohto Pharmaceutical has licensed the Obagi mark in Japan since 2002 and bought the Japanese trademarks outright in November 2025, and Waldencast has described that Japanese line as having no operational or branding overlap with the global Obagi Medical brand. So a real Japanese Obagi box is not a counterfeit, it is a different brand, and it contains no tretinoin. Beyond that, no laboratory analysis of counterfeit Obagi product could be found, so this guide does not claim what is inside a fake.

Is Obagi tretinoin FDA approved for wrinkles?+

Not according to its own label. The Obagi tretinoin cream and gel labels both give the indication as topical treatment of acne vulgaris, and the cream label adds that safety and efficacy in other disorders have not been established. A tretinoin cream approved in the US for fine facial wrinkles does exist, RENOVA 0.02% under NDA021108, held by a different company. That label is unusually blunt about its limits, stating in capitals that the product does not eliminate wrinkles or reverse photoaging.

References

DailyMed. Tretinoin Cream (Obagi Cosmeceuticals LLC) prescribing information. Marketing category New Drug Application, applications NDA017340, NDA017522 and NDA019049. Indication, vehicle, storage and pack sizes. dailymed.nlm.nih.gov
DailyMed. Tretinoin Gel, 0.05% (Obagi Cosmeceuticals LLC) prescribing information. Marketing category New Drug Application Authorized Generic, NDA022070. Source of the adverse reaction table, the trial demographics, the fish protein caution and the storage range. dailymed.nlm.nih.gov
openFDA National Drug Code directory, labeler Obagi Cosmeceuticals LLC, 50 listings. Source of the marketing category split and the four tretinoin products. api.fda.gov
openFDA drug label. RENOVA (tretinoin cream) 0.02%, NDA021108, Bausch Health US LLC. Indications and usage section, including the stated limits on what the product does. api.fda.gov
Leyden JJ, Grove GL, Grove MJ, Thorne EG, Lufrano L. Treatment of photodamaged facial skin with topical tretinoin. J Am Acad Dermatol. 1989;21(3 Pt 2):638-644. PMID 2674225. pubmed 2674225
Weinstein GD, Nigra TP, Pochi PE, et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol. 1991;127(5):659-665. PMID 2024983. pubmed 2024983
Kossard S, Anderson P, Davies A, Cooper A. Histological evaluation of the effect of 0.05% tretinoin in the treatment of photo damaged skin. Australas J Dermatol. 1993;34(3):89-95. PMID 8080420. pubmed 8080420
Pannucci CJ, Reavey PL, Kaweski S, et al. A randomized controlled trial of skin care protocols for facial resurfacing. Plast Reconstr Surg. 2011;127(3):1334-1342. PMID 21364435. pubmed 21364435
Fabi SG, Goldman MP. Comparative study of hydroquinone-free and hydroquinone-based hyperpigmentation regimens. J Drugs Dermatol. 2013;12(3):S32-37. PMID 23545931. pubmed 23545931
Dayan SH, Ho TT, Bacos JT, et al. A randomized study to assess the efficacy of skin rejuvenation therapy in combination with neurotoxin and full facial filler treatments. J Drugs Dermatol. 2018;17(1):48-54. PMID 29320587. pubmed 29320587
Waldencast plc. Press release, 14 November 2025, on the sale of the Obagi trademark rights in Japan to Rohto Pharmaceutical for USD 82.5 million, and on Rohto having licensed the mark in Japan since 2002 with no operational or branding overlap with the global Obagi Medical brand. globenewswire.com
Obagi Cosmeceuticals LLC. Authorized retailers page, including the statement that diverted product may be outdated, counterfeit or compromised, and the named retail channels the company says it does not sell to or authorise. obagi.com
Ministry of Health of Vietnam. Circular 12/2025/TT-BYT on the registration of medicines and medicinal ingredients, signed 16 May 2025, in force from 1 July 2025. Article 15 sets the principles, criteria and methods for classifying a medicine as non-prescription. Article 52, clause 2, point a ends the chemical medicines, biologicals and herbal medicines content of Circular 07/2017/TT-BYT, which issued the list of medicines that may be sold without a prescription. Article 52, clause 5 keeps existing classifications until a registration is renewed. Checked August 2026. datafiles.chinhphu.vn

How the drug data was filtered: the FDA National Drug Code records were filtered on the active_ingredients name field with an exact match on tretinoin, not a text search, so isotretinoin products cannot enter the count. The 157 DailyMed records returned for the drug_name tretinoin query were also checked for isotretinoin titles and none were present. Marketing category was read from the record rather than inferred, because a listing in a drug database is not an approval. This page makes no claim about any specific seller, tube or batch, which can only be settled for the exact unit in front of you.